| Christopher Patrick Blomberg, DO | |
|
9 Healthcare Dr Ste 105, Biddeford, ME 04005 | |
| (207) 282-3666 | |
| Not Available |
| Full Name | Christopher Patrick Blomberg |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 14 Years |
| Location | 9 Healthcare Dr Ste 105, Biddeford, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164733978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 254944 (Massachusetts) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | DO2735 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Maine Medical Center | Portland, ME | Hospital |
| Franklin Memorial Hospital | Farmington, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
The German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed the antiviral drug combination rilpivirine/emtricitabine/tenofovir. In early 2012, the combination was approved for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1) who have not received previous antiretroviral treatment.
Inherited genetic mutations can rob up to 7 percent of the population of their smile. Several genes are important for the placement and patterning of teeth.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.
Simple remedies - from keeping the antibacterial gel dispenser clean to giving health care workers their own hand sanitizer - can help keep patients safe by decreasing contamination in operating and recovery rooms, suggest two studies presented at the ANESTHESIOLOGY 2013 annual meeting.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
The German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed the antiviral drug combination rilpivirine/emtricitabine/tenofovir. In early 2012, the combination was approved for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1) who have not received previous antiretroviral treatment.
Inherited genetic mutations can rob up to 7 percent of the population of their smile. Several genes are important for the placement and patterning of teeth.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.
Simple remedies - from keeping the antibacterial gel dispenser clean to giving health care workers their own hand sanitizer - can help keep patients safe by decreasing contamination in operating and recovery rooms, suggest two studies presented at the ANESTHESIOLOGY 2013 annual meeting.
› Verified 6 days ago
| Entity Name | Southern Maine Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659392819 PECOS PAC ID: 0143208348 Enrollment ID: O20040713001060 |
News Archive
The German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed the antiviral drug combination rilpivirine/emtricitabine/tenofovir. In early 2012, the combination was approved for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1) who have not received previous antiretroviral treatment.
Inherited genetic mutations can rob up to 7 percent of the population of their smile. Several genes are important for the placement and patterning of teeth.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.
Simple remedies - from keeping the antibacterial gel dispenser clean to giving health care workers their own hand sanitizer - can help keep patients safe by decreasing contamination in operating and recovery rooms, suggest two studies presented at the ANESTHESIOLOGY 2013 annual meeting.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Patrick Blomberg, DO 1 Medical Center Dr, Biddeford, ME 04005-9422 Ph: (207) 282-3666 | Christopher Patrick Blomberg, DO 9 Healthcare Dr Ste 105, Biddeford, ME 04005 Ph: (207) 282-3666 |
News Archive
The German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed the antiviral drug combination rilpivirine/emtricitabine/tenofovir. In early 2012, the combination was approved for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1) who have not received previous antiretroviral treatment.
Inherited genetic mutations can rob up to 7 percent of the population of their smile. Several genes are important for the placement and patterning of teeth.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.
Simple remedies - from keeping the antibacterial gel dispenser clean to giving health care workers their own hand sanitizer - can help keep patients safe by decreasing contamination in operating and recovery rooms, suggest two studies presented at the ANESTHESIOLOGY 2013 annual meeting.
› Verified 6 days ago
Dr. Peter G Kachavos, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 46 Barra Rd, Biddeford, ME 04005 Phone: 207-282-3349 | |
Jennifer Cutone, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30 W Cole Rd, Biddeford, ME 04005 Phone: 207-282-3349 Fax: 207-282-6099 | |
Dr. Eva Zaslavsky, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 26 W Cole Rd, Biddeford, ME 04005 Phone: 207-294-5800 Fax: 207-294-5801 | |
Thomas Courtney, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2 Medical Center Dr, Suite 3, Biddeford, ME 04005 Phone: 207-283-8406 | |
Nadeem S Ali, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30 West Cole Road, Biddeford, ME 04005 Phone: 207-282-3349 Fax: 207-282-6099 | |
Dr. Richard Martin Kahn, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Drive, Suite 209, Biddeford, ME 04005 Phone: 207-283-6408 Fax: 207-286-1327 |